Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 4.040
-0.020 (-0.49%)
Jul 18, 2025, 2:45 PM CST
Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, medical and healthcare services, and smart supply chain for pharmaceutical and medical devices.
It also provides its products in the areas of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases, as well as anti-tumor.
Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Co.,Ltd
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,297 |
| CEO | Wu Jun Lan |
Contact Details
Address: Building B01, Entrepreneurial Headquarters Base Tianjin, 301700 China | |
| Phone | 86 22 5962 3160 |
| Website | chasesun.cn |
Stock Details
| Ticker Symbol | 300026 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000GF1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wu Jun Lan | Vice Chairman and GM |
| Wu Sun | Executive Vice President, Chief Financial Officer, Chief Accountant and Director |
| Rui Qiang Chen | Deputy General Manager |
| Chun Xu Li | Deputy GM and Director |
| Yi Yang | Secretary of the Board of Directors |
| Kun Zhang | Deputy General Manager |
| Xiao Zhong Lu | Deputy General Manager |